175 related articles for article (PubMed ID: 22374723)
1. Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients.
Caballero T; Gila A; Sánchez-Salgado G; Muñoz de Rueda P; León J; Delgado S; Muñoz JA; Caba-Molina M; Carazo A; Ruiz-Extremera A; Salmerón J
Histol Histopathol; 2012 Apr; 27(4):459-66. PubMed ID: 22374723
[TBL] [Abstract][Full Text] [Related]
2. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
[TBL] [Abstract][Full Text] [Related]
3. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
5. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease.
Ma H; Gomez V; Lu L; Yang X; Wu X; Xiao SY
J Gastroenterol Hepatol; 2009 Feb; 24(2):233-7. PubMed ID: 18713296
[TBL] [Abstract][Full Text] [Related]
6. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.
Aron-Wisnewsky J; Minville C; Tordjman J; Lévy P; Bouillot JL; Basdevant A; Bedossa P; Clément K; Pépin JL
J Hepatol; 2012 Jan; 56(1):225-33. PubMed ID: 21703181
[TBL] [Abstract][Full Text] [Related]
7. Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.
Kukla M; Ciupińska-Kajor M; Kajor M; Wyleżoł M; Żwirska-Korczala K; Hartleb M; Berdowska A; Mazur W
Pol J Pathol; 2010; 61(3):147-53. PubMed ID: 21225497
[TBL] [Abstract][Full Text] [Related]
8. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
Abrams GA; Kunde SS; Lazenby AJ; Clements RH
Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
[TBL] [Abstract][Full Text] [Related]
9. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.
Danin PE; Anty R; Patouraux S; Raucoules-Aimé M; Gugenheim J; Tran A; Gual P; Iannelli A
Obes Surg; 2018 Mar; 28(3):735-742. PubMed ID: 28875438
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
12. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
[TBL] [Abstract][Full Text] [Related]
13. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.
Xanthakos S; Miles L; Bucuvalas J; Daniels S; Garcia V; Inge T
Clin Gastroenterol Hepatol; 2006 Feb; 4(2):226-32. PubMed ID: 16469684
[TBL] [Abstract][Full Text] [Related]
14. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
15. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.
Bedossa P; Poitou C; Veyrie N; Bouillot JL; Basdevant A; Paradis V; Tordjman J; Clement K
Hepatology; 2012 Nov; 56(5):1751-9. PubMed ID: 22707395
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients.
Kroh M; Liu R; Chand B
Surg Endosc; 2007 Nov; 21(11):1957-60. PubMed ID: 17479322
[TBL] [Abstract][Full Text] [Related]
17. Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis.
Söderberg C; Marmur J; Eckes K; Glaumann H; Sällberg M; Frelin L; Rosenberg P; Stål P; Hultcrantz R
APMIS; 2011 Jul; 119(7):412-20. PubMed ID: 21635548
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease treated by gastroplasty.
Jaskiewicz K; Raczynska S; Rzepko R; Sledziński Z
Dig Dis Sci; 2006 Jan; 51(1):21-6. PubMed ID: 16416204
[TBL] [Abstract][Full Text] [Related]
19. Hepatic histology in obese patients undergoing bariatric surgery.
Machado M; Marques-Vidal P; Cortez-Pinto H
J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
[TBL] [Abstract][Full Text] [Related]
20. Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.
Arias-Loste MT; Iruzubieta P; Puente Á; Ramos D; Santa Cruz C; Estébanez Á; Llerena S; Alonso-Martín C; San Segundo D; Álvarez L; López Useros A; Fábrega E; López-Hoyos M; Crespo J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
